Article
Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.
Proceedings of the National Academy of Sciences of the United States of America - 27 May 2014
Kawasaki Kyoko, Freimuth Julia, Meyer Dominique S, Lee Marie M, Tochimoto-Okamoto Akiko, Benzinou Michael, Clermont Frederic F, Wu Gloria, Roy Ritu, Letteboer Tom G W, Ploos van Amstel Johannes Kristian, Giraud Sophie, Dupuis-Girod Sophie, Lesca Gaeten, Westermann Cornelius J J, Coffey Robert J, Akhurst Rosemary J
Abstract excerpt
Outcome of TGFβ1 signaling is context dependent and differs between individuals due to germ-line genetic variation. To explore innate genetic variants that determine differential outcome of reduced TGFβ1 signaling, we dissected the modifier locus Tgfbm3, on mouse chromosome 12. On a NIH/OlaHsd genetic background, the Tgfbm3b(C57) haplotype suppresses prenatal lethality of Tgfb1(-/-) embryos and enhances nuclear...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
